PR Newswire/Les Echos/

Press release                                          Paris, January 25, 2010

AXA Intends to Voluntarily Delist from the NYSE and Deregister with the SEC to
Focus Trading on Euronext Paris

AXA today announced its intention to voluntarily delist its American Depositary
Shares ("ADS") from the New York Stock Exchange ("NYSE") and to voluntarily
deregister with the U.S. Securities and Exchange Commission ("SEC").

As a result, AXA intends to file a Form 25 with the NYSE during the first
quarter of 2010 to effect the delisting. The delisting will be effective ten
days after this filing. Following the effectiveness of the delisting from the
NYSE, AXA intends to file a Form 15F with the SEC to deregister and terminate
its reporting obligations under the Exchange Act. The Form 15F and
deregistration will also relate to the following debt securities issued by AXA:
8.60% USD Subordinated Notes due December 15, 2030, 6.75% Euro Subordinated
Notes due December 15, 2020 and 7.125% GBP Subordinated Notes Due December 15,
2020. The deregistration is expected to become effective within 90 days after
the filing of the Form 15F.

AXA's delisting and deregistering will focus trading of its ordinary shares on
AXA's primary trading market (EuroNext Paris) which accounts for over 95% of
worldwide trading volume. The delisting and deregistration will have no impact
on the listing of AXA on Euronext Paris.

AXA intends to maintain its US ADR program as a "level one" program which will
permit AXA's current ADR holders and other US investors to continue holding and
trading AXA ADRs in the US over-the-counter market.

Henri de Castries, AXA's Chief Executive Officer, said, "The Group has derived 
a number of important benefits from its NYSE listing since 1996 including the
financial reporting discipline we have achieved thanks to our Sarbanes 404
program and we intend to ensure that this discipline is maintained with an
annual program to test the effectiveness of our internal controls going 
forward. Trading volumes and liquidity on the NYSE, ho we ver, have not 
developed to the level we had hoped when we initially listed. Since 1996, 
trading volume on the NYSE has represented a small portion of the Group's 
global trading volume (currently less than 5%) and the market has not developed
sufficient liquidity to be attractive for most institutional investors who 
continue to prefer the liquidity of our primary trading market on 
Euronext Paris. After considering all the pros and cons very carefully, we came
to the conclusion that this decision is the right move for the Group at this 
stage in its evolution because the burdens of maintaining our listing and 
registration seem disproportionate to the benefits we have derived."

AXA will also continue to publish its annual reports and other financial
communications in both English and French which will be available to US ADR
holders and other investors through AXA's website (www.axa.com).

AXA's decision to delist from the NYSE and deregister with the SEC does not 
call into question in any way the Group's strategic vision for the US which 
has been one of the Group's core markets for nearly 20 years and which will 
remain one of its core markets going forward. .


                                    *       *
                                        *

About AXA Group
AXA Group is a worldwide leader in Financial Protection. AXA's operations are
diverse geographically, with major operations in Europe, North America and the
Asia/Pacific area. For 1H09, IFRS revenues amounted to Euro 48.4 billion and
IFRS underlying earnings to Euro 2.1 billion. AXA had Euro 967 billion in 
assets under management as of June 30, 2009.
The AXA ordinary share is listed on compartment A of Euronext Paris under the
ticker symbol CS (ISIN FR0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA). 
The American Depository Share is also listed on the NYSE under the ticker 
symbol AXA.

Investor relations AXA                      Media relations AXA
Etienne Bouas-Laurent :  +33.1.40.75.46.85  Emmanuel Touzeau: +33.1.40.75.46.74
Gilbert Chahine:         +33.1.40.75.56.07  Armelle Vercken:  +33.1.40.75.46.42
Paul-Antoine Cristofari: +33.1.40.75.73.60  Chris Winans:        + 1 2123145519
Sylvie Gleises:          +33.1.40.75.49.05

IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING 
FORWARD-LOOKING STATEMENTS

Certain statements contained herein are forward-looking statements including,
but not limited to, statements that are predictions of or indicate future
events, trends, plans or objectives. Undue reliance should not be placed on 
such statements because, by their nature, they are subject to known and unknown
risks and uncertainties. Please refer to AXA's Annual Report on Form 20-F and 
AXA's Document de Référence for the year ended December 31, 2008, for a 
description of certain important factors, risks and uncertainties that may 
affect AXA's business. In particular, please refer to the section "Special Note
Regarding Forward-Looking Statements" in AXA's Annual Report on Form 20-F. AXA 
undertakes no obligation to publicly update or revise any of these 
forward-looking statements, whether to reflect new information, future events 
or circumstances or otherwise.
                      
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.